AACAP Physician Scientist Program in Substance Abuse

AACAP 药物滥用医师科学家计划

• 批准号: 9292272
• 负责人: Paula DeGraffenreid Riggs
• 金额: $ 132.9万
• 依托单位: AMERICAN ACADEMY-CHILD/ADOLESCENT PSYCH
• 依托单位国家: 美国
• 财政年份: 1998
• 资助国家: 美国
• 起止时间: 1998-01-01 至 2020-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9292272
• 关键词: Address; Adolescence; Adolescent; Award; Child; Childhood; Clinical Trials Network; Country; Development; Drug Addiction; Drug abuse; Funding; Home environment; Institute of Medicine (U.S.); Intervention; Lead; Leadership; Mental Health; Mentored Clinical Scientist Development Program; Mentors; National Institute of Drug Abuse; Physicians; Positioning Attribute; Prevention; Psychiatrist; Psychopathology; Public Health; Research; Research Personnel; Research Training; Resources; Risk; SECTM1 gene; Scientist; Substance Use Disorder; Substance abuse problem; Training; Translating; Youth; addiction; career; career development; evidence base; meetings; programs; success; training opportunity

 DESCRIPTION (provided by applicant): This competing renewal application for a NIDA Mentored Clinical Scientists Development Program Award in Drug Abuse and Addiction (K12; PAR-13-163) addresses the critical shortage of child and adolescent psychiatrists (CAPs) dually-trained in developmental psychopathology and addiction research. This is of great public health concern given ample research showing that the majority of psychiatric and substance use disorders emerge during childhood or adolescence and most often are co-occurring. According to the Institute of Medicine, this shortage has contributed to broad research gaps and a lack of effective evidence based prevention and treatment. Given their specialized training in developmental psychopathology, CAPs who go on the receive additional addiction research training may in the best position to address existing research gaps that may lead to the development of new or more effective prevention and treatment interventions for the growing number of our nation's youth who are at risk or who have developed co- occurring substance and mental health problems. Since Program inception in 1998, the NIDA/AACAP K12 Program has successfully cultivated the careers of seventeen CAP investigators. Sixteen of the seventeen have established or are well on their way to establishing careers in drug abuse and mental health research (Aim 1). Under the Program leadership of Dr. Riggs, the AACAP K12 established an ongoing partnership with the NIDA Clinical Trials Network as a training platform for AACAP K12 scholars in 2005. This partnership has significantly and meaningfully expanded the national network of senior addiction research mentors, academic research centers and training opportunities for K12 scholars (Aim 2). AACAP continues to be an ideal institutional home for the K12 given its strong institutional commitment, ample resources, and membership that includes more than 95% of CAPs in the country, including all current and previous K12 scholars. AACAP is well positioned to continue its commitment and support of scholars' career development, if the renewal is funded. Moreover, scholars' research presentations at AACAP Annual Meetings facilitate and accelerate the pace at which their research is translated into practice and impacts the field. Despite considerable Program progress towards achieving the aims of this award, the "crisis-level" national shortage of CAP clinicians continues. Fewer than 2% of CAPs devote significant effort to research and less than 1/2 of 1% have established careers in addiction research. This application proposes to continue building on the success of the AACAP K12 Program by addressing the following aims, which remain unchanged: Aim 1: To increase the number of independently-funded CAP addiction researchers; and Aim 2: To further expand the network of senior mentors and addiction research training centers and opportunities for K12 scholars and other early investigators.

 描述(由申请人提供)：NIDA指导的药物滥用和成瘾临床科学家发展计划奖(K12；PAR-13-163)的竞争续签申请解决了在发育精神病理学和成瘾研究方面接受双重培训的儿童和青少年精神病学家(CAPS)的严重短缺问题。鉴于充分的研究表明，大多数精神障碍和药物使用障碍出现在儿童或青少年时期，而且大多数情况下是同时发生的，这是一个非常令人担忧的公共卫生问题。根据医学研究所的说法，这种短缺导致了广泛的研究差距和缺乏有效的循证预防和治疗。鉴于他们在发展精神病理学方面的专门训练，继续接受额外成瘾研究培训的CAPS可能最有可能弥补现有的研究差距，这些差距可能导致为我国越来越多的面临风险或患有共生物质和精神健康问题的青年制定新的或更有效的预防和治疗干预措施。自1998年项目启动以来，NIDA/AACAP K12项目已经成功培养了17名CAP调查人员的职业生涯。这17人中有16人已经或正在建立药物滥用和心理健康研究方面的事业(目标1)。在Riggs博士的项目领导下，AACAP K12于2005年与NIDA临床试验网络建立了持续的合作伙伴关系，作为AACAP K12学者的培训平台。这一伙伴关系显著和有意义地扩大了全国高级成瘾研究导师网络、学术研究中心和K12学者的培训机会(Aim 2)。鉴于其强大的机构承诺、充足的资源和成员包括全国超过95%的CAP，包括所有现任和前任K12学者，AACAP仍然是K12的理想机构所在地。AACAP处于有利地位，如果续签获得资金，将继续致力于并支持学者的职业发展。此外，学者们在AACAP年会上的研究报告促进和加快了他们的研究转化为实践并影响该领域的步伐。尽管该计划在实现该奖项的目标方面取得了相当大的进展，但“危机级别”的全国CAP临床医生短缺仍在继续。不到2%的CAP将大量精力投入到研究中，1%的CAP中只有不到一半的人在成瘾研究方面建立了职业生涯。本申请建议继续在AACAP K12计划成功的基础上，解决以下目标，这些目标保持不变：目标1：增加独立资助的CAP成瘾研究人员的数量；以及目标2：进一步扩大高级导师和成瘾研究培训中心的网络，并为K12学者和其他早期研究者提供机会。